Literature DB >> 8686803

Safety of 65 degrees C intravenous fluid for the treatment of hypothermia.

C M Sheaff1, J J Fildes, P Keogh, R F Smith, J A Barrett.   

Abstract

BACKGROUND: To demonstrate the safety and efficacy of 65 degrees C (149 degrees F) centrally administered intravenous fluid (CIVF) compared to conventional 40 degrees C (104 degrees F) CIVF in the treatment of hypothermia.
METHOD: Ten beagles (9-13 kg) were prospectively randomized to receive 65 degrees C or 40 degrees C CIVF. They were anesthetized and data were collected at baseline, during hypothermia, and after 1 and 2 hours of rewarming. The plasma free/total hemoglobin (PFHb/THb) was measured to detect hemolysis. Each subject was cooled to 30 degrees C (86 degrees F) and then received either 65 degrees C or 40 degrees C CIVF through a specialized catheter in the superior vena cava for 2 hours in addition to conventional rewarming techniques. All subjects survived 7 days, after which they were sacrificed and a complete autopsy was performed.
RESULTS: The rewarming rate was 3.7 degrees C/hr in the 65 degrees C CIVF group and 1.75 degrees C/hr in the 40 degrees C CIVF group. Core temperatures were significantly different after 1 hour (33.4 degrees +/- 0.77 degrees versus 31.7 degrees +/- 0.57 degrees, P < 0.01) and 2 hours (37 degrees +/- 1.03 degrees versus 33.4 degrees +/- 0.89 degrees, P < 0.001). PFHb/THb was not different. Two intimal injuries occurred in each group but these were remote from the infusion site. Blinded examination by two pathologists could not differentiate the etiology of these injuries from mechanical trauma.
CONCLUSION: CIVF at 65 degrees C is a safe and effective means of treating hypothermia.

Entities:  

Mesh:

Year:  1996        PMID: 8686803     DOI: 10.1016/S0002-9610(96)00055-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Neonatal Piglet Temperature Changes: Effect of Intraperitoneal Warm Saline Injection.

Authors:  Bryony S Tucker; Kiro R Petrovski; Roy N Kirkwood
Journal:  Animals (Basel)       Date:  2022-05-20       Impact factor: 3.231

2.  [Evaluation of a new insulating system for infusion solutions in preclinical trauma therapy: a prospective, randomized study].

Authors:  Thomas Scheck; Alexander Kober; Peter Heigl; Edeltraud Schiller; Peter Buda; Gabor Szvitan; Frank Lieba; Klaus Hoerauf
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 2.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.